- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Seattle Genetics Inc+ Add to Watchlist
SGEN:US37.4000 USD 1.0700 2.95%
As of 20:10:00 ET on 07/11/2014.
Company Profile for Seattle Genetics Inc (SGEN)
Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.
Seattle Genetics Inc
Key Executives for Seattle Genetics Inc (SGEN)
|Clay B SiegallChairman/Pres/CEO/Co-Founder||Todd E SimpsonChief Financial Officer|
|Eric L DobmeierCOO/Secretary||Jonathan DrachmanExec VP:Research & Dev|
|Vaughn B HimesExec VP:Technical Ops||Chris BoernerExec VP:Commercial|